Apogee Therapeutics, Inc. ($APGE)
Filing Information
| Accession Number | 0001104659-26-058129 |
|---|---|
| Form Type | 4 |
| Filing Date | May 9, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
13,750
Total Value
$557,081.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 4,125 | $22.86 | $94,297.50 | 212,523 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 3,700 | $83.92 | $310,504.00 | 208,823 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 6, 2026 | Sale | 1,800 | $84.60 | $152,280.00 | 207,023 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 4,125 | $0.00 | $0.00 | 123,040 | Direct | โ | View Details |